对COVID-19肺部活检的综合免疫和蛋白质组分析

Shanye Yin1,2, Susan Klaeger3, Vipheaviny A Chea1,4

  • 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.

Frontiers in immunology
|November 9, 2023
PubMed
概括

严重的COVID-19肺部疾病涉及组织修复和免疫细胞激活,特别是呈现抗原的巨细胞. 新的蛋白质签名可以预测严重的感染,突出显示大细胞驱动的免疫力在COVID-19的发病性.